Author:
Emami-Ardekani Ali Reza,Karamzade-Ziarati Najmeh,Salehi Yalda,Manafi-Farid Rehaneh,Fard-Esfahani Armaghan,Geramifar Parham,Beiki Davood,Akhlaghi Mehdi,Fallahi Babak, , , , , , , , ,
Reference46 articles.
1. Agate L, Lorusso L, Elisei R. New and old knowledge on differentiated thyroid cancer epidemiology and risk factors. J Endocrinol Invest 2012; 35(6 Suppl): 3-9.
2. Ardeshir Larijani Mb, Mohagheghi Sma, Mousavi Jarahi Sar, et al. Thyroid Cancer In Iran: An Epidemiological Survey Based On Cancer Data's Registered In Tehran. J Med Council Iran 2005; 23(4): 362-367.
3. Salari N, Kazeminia M, Mohammadi M. The Prevalence of Thyroid Cancer in Iran: a Systematic Review and Meta-analysis. Indian J Surg Oncol 2021; 2021(6): 1-11.
4. Caetano R, Bastos CR, de Oliveira IA, et al. Accuracy of positron emission tomography and positron emission tomography-CT in the detection of differentiated thyroid cancer recurrence with negative 131I whole-body scan results: A meta-analysis. Head Neck 2016; 38(2): 316-27.
5. Kist JW, de Keizer B, Stokkel MP, et al. Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study. BMC cancer 2014; 14: 405.